Literature DB >> 10933605

Development of the antibody repertoire in rabbit: gut-associated lymphoid tissue, microbes, and selection.

D Lanning1, X Zhu, S K Zhai, K L Knight.   

Abstract

Rabbits generate their antibody repertoire in three stages. First, a neonatal repertoire is generated by B lymphopoiesis in fetal liver and bone marrow and is limited by preferential V(H) gene segment usage. Between 4 and 8 weeks after birth a complex primary antibody repertoire is developed by somatically diversifying the neonatal repertoire through somatic hypermutation and a somatic gene conversion-like mechanism in gut-associated lymphoid tissue (GALT). In rabbits, unlike other species, the development of the primary antibody repertoire through somatic diversification of Ig genes appears to be dependent on intestinal microbial flora. The primary antibody repertoire is subsequently modified during antigen-dependent immune responses in which VDJ genes further diversify both by somatic hypermutation and by a gene conversion-like mechanism (the secondary repertoire). During the various stages of development, the antibody repertoire is modified and shaped by selective processes. In this review, we discuss the roles of GALT, microbes, and B-cell selection in generating antibody diversity in rabbits.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933605

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  29 in total

1.  An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site.

Authors:  Fatima K Ahmed; Brenda E Clark; Dennis R Burton; Ralph Pantophlet
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

Review 2.  Surveillance B lymphocytes and mucosal immunoregulation.

Authors:  Peter Velázquez; Bo Wei; Jonathan Braun
Journal:  Springer Semin Immunopathol       Date:  2004-12-18

3.  Immunology: B-cell development in the gut.

Authors:  Mark Schlissel
Journal:  Nature       Date:  2013-08-21       Impact factor: 49.962

4.  Generic approach for the generation of stable humanized single-chain Fv fragments from rabbit monoclonal antibodies.

Authors:  Leo Borras; Tea Gunde; Julia Tietz; Ulrich Bauer; Valérie Hulmann-Cottier; John P A Grimshaw; David M Urech
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

5.  Sequencing of Sylvilagus VDJ genes reveals a new VHa allelic lineage and shows that ancient VH lineages were retained differently in leporids.

Authors:  Ana Pinheiro; José Melo-Ferreira; Joana Abrantes; Nicola Martinelli; Antonio Lavazza; Paulo C Alves; Christian Gortázar; Pedro J Esteves
Journal:  Immunogenetics       Date:  2014-09-30       Impact factor: 2.846

6.  BCR selection and affinity maturation in Peyer's patch germinal centres.

Authors:  Huan Chen; Yuxiang Zhang; Adam Yongxin Ye; Zhou Du; Mo Xu; Cheng-Sheng Lee; Joyce K Hwang; Nia Kyritsis; Zhaoqing Ba; Donna Neuberg; Dan R Littman; Frederick W Alt
Journal:  Nature       Date:  2020-05-06       Impact factor: 49.962

7.  Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.

Authors:  Jidnyasa Ingale; Karen Tran; Leopold Kong; Barna Dey; Krisha McKee; William Schief; Peter D Kwong; John R Mascola; Richard T Wyatt
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

8.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

9.  Ultrastructural changes of adult Schistosoma mansoni worms recovered from C57BL/6 mice passively immunized with normal and vaccinated rabbit sera in vivo.

Authors:  Sherif H Abdeen; Enayat S Reda; Eman A El-Shabasy; Allal Ouhtit
Journal:  Parasitol Res       Date:  2011-05-26       Impact factor: 2.289

Review 10.  Bone marrow fat and the decline of B lymphopoiesis in rabbits.

Authors:  Domenick E Kennedy; Pamela L Witte; Katherine L Knight
Journal:  Dev Comp Immunol       Date:  2015-11-11       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.